| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $329.0M | +40.8% |
| Cost of Revenue | $38.5M | +172.4% |
| R&D Expense | $94.3M | +23.8% |
| SG&A Expense | $154.3M | +25.7% |
| Operating Income | $41.9M | +103.2% |
| Pre-tax Income | $25.6M | +95.9% |
| Income Tax | $2.2M | +466.9% |
| Net Income | $23.4M | +84.5% |
| EPS (Basic) | $0.16 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $179.9M | +93.6% |
| Short-term Investments | $131.1M | +5.2% |
| Accounts Receivable | $129.2M | +152.8% |
| Inventory | $110.5M | +177.4% |
| Current Assets | $566.4M | +78.1% |
| Total Assets | $577.7M | +75.3% |
| Current Liabilities | $90.7M | +68.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.5M | -29.0% |
| Capital Expenditures | $45K | — |
| Investing Cash Flow | -$1.0M | +98.0% |
| Financing Cash Flow | $128.5M | +76.8% |
| Free Cash Flow | -$40.6M | -29.1% |
| +77.8% |
| EPS (Diluted) | $0.15 | +66.7% |
| Long-term Debt |
| $244.4M |
| +143.4% |
| Total Liabilities | $355.3M | +110.1% |
| Stockholders' Equity | $222.4M | +38.5% |